Lymphoproliferative disease and acquired C1 inhibitor deficiency

* Division of Internal Medicine, Department of Internal Medicine and Medical Specialities IRCCS Fondazione Ospedale Maggiore Policlinico of Milan, Milan, Italy ° Clinica Ematologia, TMO Università degli Studi di Milano, Bicocca Ospedale San Gerardo di Monza; II Division of Internal Medicine, Sacco H...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 92; no. 5; pp. 716 - 718
Main Authors Castelli, Roberto, Deliliers, Daniela Lambertenghi, Zingale, Lorenza C, Pogliani, Enrico Maria, Cicardi, Marco
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.05.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:* Division of Internal Medicine, Department of Internal Medicine and Medical Specialities IRCCS Fondazione Ospedale Maggiore Policlinico of Milan, Milan, Italy ° Clinica Ematologia, TMO Università degli Studi di Milano, Bicocca Ospedale San Gerardo di Monza; II Division of Internal Medicine, Sacco Hospital, University of Milan, Italy Correspondence: Roberto Castelli, MD, Department of Internal Medicine and Medical Specialities, IRCCS Fondazione Ospedale Maggiore Policlinico of Milan, via Pace 9, 20122 Milan, Italy. Phone: international +39.02.55035320. Fax: international +39.02.55034722. E-mail: castelli39{at}interfree.it Angioedema due to acquired deficiency of the C1-inhibitor is a bridging condition between autoimmunity and lymphoproliferation. We report 32 patients with acquired C1 inhibitor deficiency: 23 have anti C1-inhibitor autoantibodies; 13 have monoclonal gammopathies of unknown significance and 9 have non-Hodgkin’s lymphoma. Our series suggest that different forms of B cell disorders coexist and/or evolve into each other in acquired angioedema. Key words: C1 inhibitor, deficiency, acquired, lymphoproliferative, autoantibody.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.10769